Nahla Hasabou
Nahla Hasabou publishes mostly in Hematology, Genetics and Oncology, on topics such as Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors and Chronic Lymphocytic Leukemia Research.
- World rank
- #920,719 of 1,633,909 ranked researchers
- Rank in United States
- #250,601 of 358,040
- Works
- 18
- Citations
- 22
- Citations per work
- 1.2
What does Nahla Hasabou research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Hematology30% of their works
- 2Genetics15% of their works
- 3Oncology15% of their works
- 4Molecular Biology15% of their works
- 5Pulmonary and Respiratory Medicine10% of their works
- 6Cancer Research5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Protein Degradation and Inhibitors
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Colorectal Cancer Screening and Detection
- Breast Cancer Treatment Studies
- Histone Deacetylase Inhibitors Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Nahla Hasabou's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, BCR-ABL, BET Bromodomains, Chronic Lymphocytic Leukemia, Colorectal Cancer and Gene Expression.
- Treatment Response
- JAK2 Mutation
- HDAC Inhibitors
- Screening
- Imatinib
- Gene Expression
- Chronic Lymphocytic Leukemia
- BCR-ABL
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- BET Bromodomains
- Colorectal Cancer
- Genomic Aberrations
- PROTACs
- Breast Tumours
- Histone Deacetylases
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors62 topics
- AML41 topic
- Acute Myeloid Leukemia41 topic
- BCR-ABL21 topic
- BET Bromodomains21 topic
- Chronic Lymphocytic Leukemia21 topic
- Colorectal Cancer21 topic
- Gene Expression22 topics
- Genomic Aberrations21 topic
- Imatinib21 topic
- PROTACs21 topic
- Screening21 topic
- Breast Tumours11 topic
- HDAC Inhibitors11 topic
- Histone Deacetylases11 topic
- JAK2 Mutation11 topic
- Myelofibrosis11 topic
- Treatment Response11 topic
Where does Nahla Hasabou work?
Nahla Hasabou's main affiliation in the publication record is Astellas Pharma (United States), United States.
How many publications and citations does Nahla Hasabou have?
Science Explorer counts 18 works and 22 citations for Nahla Hasabou, ranking #920,719 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.